- Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular data center infrastructure

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033¹

Trinity Biotech plc (NASDAQ: TRIB) today announced that Trinovium, a subsidiary focused on advanced liquid cooling solutions and fluid intelligence systems for next-generation AI data centers, has agreed to enter into a strategic collaboration agreement with Echelon Data Centres (“Echelon”), a leading hyperscale data center owner, developer and operator, to develop next-generation high-performance liquid cooling solutions for AI and high-density computing environments.

This collaboration with Echelon will bring together Trinovium’s expertise in ultra-high-purity fluid manufacturing and analytical technologies, with Echelon’s deep understanding of hyperscale data center infrastructure requirements. The parties will work to further the development and in the field refinement of advanced liquid cooling technologies designed to address the growing thermal management challenges associated with AI workloads and next-generation computing architectures.

Echelon is developing one of the largest hyperscale data center portfolios in Europe, with more than 700 MW currently in development, over 1.4 GW of secured capacity, and more than 4 million square meters of data center space across multiple development regions.

The agreement represents a further step in Trinovium’s strategy to leverage Trinity Biotech’s decades of experience in precision fluid development, manufacturing, analytics and quality systems to address emerging opportunities within AI infrastructure and data center cooling markets. The parties expect to commence development activities imminently, with initial focus areas including direct-to-chip cooling fluids, thermal management systems and modular liquid cooling solutions optimized for AI and high-performance computing deployments.

John Gillard, Chief Executive Officer of Trinity Biotech, commented:

“The rapid growth of AI is creating unprecedented demand for advanced cooling technologies capable of supporting increasingly dense and power-hungry computing environments. By combining Trinovium’s capabilities in high-performance fluid design, precision manufacturing and advanced analytics with Echelon’s hyperscale data center expertise we believe we can accelerate the development of innovative liquid cooling solutions designed specifically for the next generation of AI infrastructure.”

Niall Molloy, Chief Executive Officer of Echelon Data Centres, commented:

“AI is changing the infrastructure requirements of data centers. As more computing power is concentrated into smaller spaces, managing the heat it generates becomes an increasingly important engineering challenge. Liquid cooling will be an important part of meeting that challenge, but it is not simply about moving heat more efficiently. The quality, stability and monitoring of the fluids within those systems will also be important to their long-term reliability.

“This collaboration brings together Trinovium’s expertise in fluid science and analytics with our experience of developing hyperscale infrastructure. It gives us an opportunity to develop and refine technologies specifically around the requirements of the next generation of AI data centers.”

Trinovium is entering a market where rising AI driven data center power densities are making coolant purity, stability, and monitoring increasingly important to system reliability. As coolant temperatures and operating demands increase, factors such as corrosion, particulate contamination, fluid degradation, and microbial growth are becoming increasingly important determinants of system reliability and uptime.

Building upon Trinity Biotech’s expertise in healthcare-grade fluid manufacturing, Trinovium has developed an initial direct-to-chip liquid cooling formulation designed around three core performance requirements and the relevant Open Compute Project guidelines:

• Ultra-high-purity, highly stable aqueous chemistry;
• Corrosion inhibition, and coolant system protection; and
• Healthcare-level consistency and traceability.

Alongside its initial direct-to-chip cooling fluid formulation, Trinovium is working to advance a fluid health and system intelligence platform drawing on Trinity Biotech’s broad analytical technology portfolio, including connected electrochemical sensing and mass spectrometry capabilities acquired through recent strategic transactions. The platform is being designed to monitor corrosion and scaling, particulate contamination and microbial growth and biofilm formation, creating a high-margin, recurring revenue layer that moves the business model toward data-driven performance optimization.